Pricing
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
Industries
Headquarters
Employees
Links
Full screen
William Conkling
View all
7 people · 0 jobs
HQ
1 person · 0 jobs
Tango Therapeutics
3 followers
Cellares
4 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Illumina
79 followers
Agilent Technologies
81 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
GRAIL
28 followers
Cytiva
16 followers
PerkinElmer
12 followers
Explore companies